ProPhase Labs, Inc. Stock Issued During Period, Shares, Other
ProPhase Labs, Inc. (PRPH) reported Stock Issued During Period, Shares, Other of 300.00 thousand shares for the 1-month period ending 2014-12-31, per its 10-K filed 2016-03-29.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesOther · last filed 2016-03-29
- 2014-12-31: Stock Issued During Period, Shares, Other 1 month 300.00K shares.
| Period end | Stock Issued During Period, Shares, Other 1 month |
|---|---|
| 2014-12-31 | 300.00K shares 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |